Researchers have been excited about the medication , a groundbreaking dual agonist showing significant results in early trials for body loss . It acts by impacting two hormones : GLP-1 and GIP, that , https://aoifevlmq060341.jaiblogs.com/67827215/a-new-possibility-for-size-loss